To determine the success of any juvenile-onset myopia intervention, it is vital to consider the target for myopia progression management. Is the treatment goal to stop axial length growth or simply slow progression? How should axial length growth in children undergoing myopia management treatment be compared to average eye growth in emmetropic children of the same age? What treatment effect is required to be considered clinically meaningful? Most myopic children, especially those of East Asian ancestry, in the age range of 6-10 years old, if untreated, will manifest axial elongation ~0.30 – 0.40 mm per year. However, not all children are average. Some children may be faster progressors, and others may be poor respondents. These children may require combination therapy to achieve intervention goals. Read More